Corrigendum

Gene Therapy (2007) 14, 382. doi:10.1038/sj.gt.3302926

Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis

M C Leslie1, Y-J Zhao1, L B Lachman2, P Hwu3, G-J Wu4 and M Bar-Eli1

  1. 1Unit 173, Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  2. 2Unit 173, Department of Experimental Therapeutic, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  3. 3Unit 173, Department of Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  4. 4Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA, USA
Top

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated

NEWS AND VIEWS

DisSARMing Toll-like receptor signaling

Nature Immunology News and Views (01 Oct 2006)

Extra navigation

.

naturejobs

ADVERTISEMENT